About Nia Therapeutics
Nia Therapeutics is a private company based in Allston, Massachusetts. It has reported $26,123,844 raised in five offerings on Form D since November 2018. Its chief executive is Michael Kahana.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Feb 14, 2024amended Feb 20, 2024 | $0of $1 target | 0 | — | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 22, 2021 | Dec 30, 2021amended Jun 3, 2026 | $23,573,844of $26.4M target | 37 | $637K | EquityRule 506(b) | Form D/A ↗7 earlier filings |
| Jul 8, 2020 | Sep 4, 2020 | $1,500,000of $2.0M target | 3 | $500K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 4, 2019 | Sep 12, 2019 | $200,000of $2.0M target | 1 | $200K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 31, 2018 | Nov 13, 2018 | $850,000of $2.0M target | 3 | $283K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, five offerings | $26,123,844 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Nia Therapeutics's Form D filed Feb 20, 2024.
Earlier filings also listed Daniil Utin (executive officer, last listed Feb 2024).
Sources
- SECNia Therapeutics, Inc. Form D/A, filed Mar 6, 2026
- SECNia Therapeutics, Inc. Form D/A, filed Jul 17, 2025
- SECNia Therapeutics, Inc. Form D/A, filed Nov 25, 2024
- SECNia Therapeutics, Inc. Form D/A, filed Feb 20, 2024
- SECNia Therapeutics, Inc. Form D, filed Feb 14, 2024
- SECNia Therapeutics, Inc. Form D/A, filed Dec 19, 2023
- SECNia Therapeutics, Inc. Form D/A, filed Dec 23, 2022
- SECNia Therapeutics, Inc. Form D, filed Dec 30, 2021
- SECNia Therapeutics, Inc. filing history
- CompanyAbout Nia Therapeutics